Selected research
Market Structure
Global Lornoxicam Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Lornoxicam Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Lornoxicam Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Lornoxicam Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lornoxicam Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Lornoxicam Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lornoxicam Tablets include Glenmark, Lupin Limited, Takeda Pharmaceuticals, Shandong Jincheng Pharmaceutical and Zhejiang Zhenyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Lornoxicam Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Lornoxicam Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Lornoxicam Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lornoxicam Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Lornoxicam Tablets Segment by Company
Glenmark
Lupin Limited
Takeda Pharmaceuticals
Shandong Jincheng Pharmaceutical
Zhejiang Zhenyuan Pharmaceutical
Lornoxicam Tablets Segment by Type
4mg
8mg
Lornoxicam Tablets Segment by Application
Hospital and Clinic
Pharmacy
Lornoxicam Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lornoxicam Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lornoxicam Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lornoxicam Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Lornoxicam Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lornoxicam Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lornoxicam Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Lornoxicam Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 4mg
- 8mg
Applications
- Hospital and Clinic
- Pharmacy
Companies covered
- Glenmark
- Lupin Limited
- Takeda Pharmaceuticals
- Shandong Jincheng Pharmaceutical
- Zhejiang Zhenyuan Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Lornoxicam Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Lornoxicam Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Lornoxicam Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Lornoxicam Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Lornoxicam Tablets Market Dynamics
- 2.1 Lornoxicam Tablets Industry Trends
- 2.2 Lornoxicam Tablets Industry Drivers
- 2.3 Lornoxicam Tablets Industry Opportunities and Challenges
- 2.4 Lornoxicam Tablets Industry Restraints
3 Lornoxicam Tablets Market by Manufacturers
- 3.1 Global Lornoxicam Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Lornoxicam Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Lornoxicam Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Lornoxicam Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lornoxicam Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Lornoxicam Tablets Manufacturers, Product Type & Application
- 3.7 Global Lornoxicam Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Lornoxicam Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Lornoxicam Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Lornoxicam Tablets Tier 1, Tier 2, and Tier 3
4 Lornoxicam Tablets Market by Type
- 4.1 Lornoxicam Tablets Type Introduction
- 4.1.1 4mg
- 4.1.2 8mg
- 4.2 Global Lornoxicam Tablets Sales by Type
- 4.2.1 Global Lornoxicam Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Lornoxicam Tablets Sales by Type (2021-2032)
- 4.2.3 Global Lornoxicam Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Lornoxicam Tablets Revenue by Type
- 4.3.1 Global Lornoxicam Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Lornoxicam Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Lornoxicam Tablets Revenue Market Share by Type (2021-2032)
5 Lornoxicam Tablets Market by Application
- 5.1 Lornoxicam Tablets Application Introduction
- 5.1.1 Hospital and Clinic
- 5.1.2 Pharmacy
- 5.2 Global Lornoxicam Tablets Sales by Application
- 5.2.1 Global Lornoxicam Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Lornoxicam Tablets Sales by Application (2021-2032)
- 5.2.3 Global Lornoxicam Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Lornoxicam Tablets Revenue by Application
- 5.3.1 Global Lornoxicam Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Lornoxicam Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Lornoxicam Tablets Revenue Market Share by Application (2021-2032)
6 Global Lornoxicam Tablets Sales by Region
- 6.1 Global Lornoxicam Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Lornoxicam Tablets Sales by Region (2021-2032)
- 6.2.1 Global Lornoxicam Tablets Sales by Region (2021-2026)
- 6.2.2 Global Lornoxicam Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Lornoxicam Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Lornoxicam Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Lornoxicam Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Lornoxicam Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Lornoxicam Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Lornoxicam Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Lornoxicam Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Lornoxicam Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Lornoxicam Tablets Revenue by Region
- 7.1 Global Lornoxicam Tablets Revenue by Region
- 7.1.1 Global Lornoxicam Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Lornoxicam Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Lornoxicam Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Lornoxicam Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Lornoxicam Tablets Revenue (2021-2032)
- 7.2.2 North America Lornoxicam Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Lornoxicam Tablets Revenue (2021-2032)
- 7.3.2 Europe Lornoxicam Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Lornoxicam Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Lornoxicam Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Lornoxicam Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Lornoxicam Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Glenmark
- 8.1.1 Glenmark Company Information
- 8.1.2 Glenmark Business Overview
- 8.1.3 Glenmark Lornoxicam Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Glenmark Lornoxicam Tablets Product Portfolio
- 8.1.5 Glenmark Recent Developments
- 8.2 Lupin Limited
- 8.2.1 Lupin Limited Company Information
- 8.2.2 Lupin Limited Business Overview
- 8.2.3 Lupin Limited Lornoxicam Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Lupin Limited Lornoxicam Tablets Product Portfolio
- 8.2.5 Lupin Limited Recent Developments
- 8.3 Takeda Pharmaceuticals
- 8.3.1 Takeda Pharmaceuticals Company Information
- 8.3.2 Takeda Pharmaceuticals Business Overview
- 8.3.3 Takeda Pharmaceuticals Lornoxicam Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Takeda Pharmaceuticals Lornoxicam Tablets Product Portfolio
- 8.3.5 Takeda Pharmaceuticals Recent Developments
- 8.4 Shandong Jincheng Pharmaceutical
- 8.4.1 Shandong Jincheng Pharmaceutical Company Information
- 8.4.2 Shandong Jincheng Pharmaceutical Business Overview
- 8.4.3 Shandong Jincheng Pharmaceutical Lornoxicam Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shandong Jincheng Pharmaceutical Lornoxicam Tablets Product Portfolio
- 8.4.5 Shandong Jincheng Pharmaceutical Recent Developments
- 8.5 Zhejiang Zhenyuan Pharmaceutical
- 8.5.1 Zhejiang Zhenyuan Pharmaceutical Company Information
- 8.5.2 Zhejiang Zhenyuan Pharmaceutical Business Overview
- 8.5.3 Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Product Portfolio
- 8.5.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Lornoxicam Tablets Value Chain Analysis
- 9.1.1 Lornoxicam Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Lornoxicam Tablets Production Mode & Process
- 9.2 Lornoxicam Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Lornoxicam Tablets Distributors
- 9.2.3 Lornoxicam Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst